Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.
Status:
COMPLETED
Trial end date:
2024-09-05
Target enrollment:
Participant gender:
Summary
This is a Phase I/Ib, randomised, double-blind, placebo-controlled study of INI-2004, administered as single or multiple doses. This study will be conducted in two parts: Phase I single ascending dose (SAD) and Phase Ib multiple ascending dose (MAD).